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In recent years, many observers have advocated the adoption of a new
paradigm in the environmental health sciences—a shift toward a
sharper focus on understanding human disease and improving human
health by integrating knowledge from environmental health research
with that from the broad spectrum of medical research. We term this
the “disease-first” approach. The first step in this approach is to priori-
tize specific common diseases according to the public health burden
they pose. Next researchers will gather information on molecular
changes that accompany the pathogenesis of each condition, including
cellular and tissue changes that occur over time. We will then work to
link these biological responses to environmental exposures including
toxicants, metals, toxins, and lifestyle and dietary factors that eventu-
ally lead to disease. The fundamental goal of the NIEHS is to learn
how this knowledge can be used to reduce morbidity and extend
longevity. We believe the disease-first approach will allow our field to
greatly reduce the burden of human disease.
The common diseases that account for the bulk of the public
health burden of disease are chronic, disabling, and widely preva-
lent. Diseases such as asthma, obstructive lung diseases, and diabetes
mellitus are leading causes of death in the United States and are
increasing in incidence. These diseases are multifactorial and it is
recognized that environmental exposures are a key risk factor in all
of them, but large gaps exist in our ability to characterize the com-
plex associations among environmental factors, genetic factors,
and health outcomes. Gene–gene, gene–environment, and
gene–vector–environment interactions all play important roles in
any given condition. Thanks to advancing technologies in areas
such as genomics, proteomics, and metabolomics, as well as in com-
putational biology and bioinformatics, we now have the tools to
redefine exposure–response relationships, develop quantitative mod-
els to support risk assessment, and reach more comprehensive
understanding of the diverse and complex responses leading to
pathogenesis. One of the key elements of the disease-first approach
is to more fully leverage knowledge from these burgeoning tech-
nologies to vastly improve clinical outcomes. 
The first priority of the disease-first approach is to more systemati-
cally track population health status in the United States, both tempo-
rally and spatially. Improved surveillance of health status can point to
differences in exposures, which can be used as starting points for
causality research. Although a comprehensive health status monitoring
system does not yet exist, recent developments at the federal level sug-
gest that it could soon be a reality [see Kyle et al., p. 980 this issue].
Such monitoring will allow for human body burden measure-
ments of hazardous substances and xenobiotic metabolites. The
disease-first approach will integrate this information with ongoing
measurements from traditional environmental exposure assessments.
These might include measurement of atmospheric pollutants and
research on the fate and transport of hazardous agents in the ecosys-
tem. The NIEHS will develop a number of exposure-based bioassays
that will classify exposures (e.g., metals, chemicals, air pollution, diet)
and link them to risk factors for developing clinical disease or to early
steps in a disease process. Use of improved animal models of human
disease will enable research on temporal aspects of dose–response
relationships for harmful agents or lifestyle factors, facilitating the
discovery of molecular signatures of thresholds separating the normal
stress response from pathology. Such knowledge of thresholds will
allow us to predict responses to stressors and to understand how indi-
vidual susceptibility affects those responses. 
Both population-based research and clinical research on individu-
als will be needed to ascertain correlations between “real world”
exposures over ranges of dose, time, and disease, while accounting for
genetic variations among subpopulations. By linking traditional expo-
sure information with exposure responses, we can gain knowledge of
diseases and early disease processes that will accelerate our understand-
ing of both individual susceptibility and disease pathogenesis.
Many new tools will be required to accomplish these goals, some
of which are now becoming available and others of which will soon
be possible. We have seen the rapid maturation of novel, high-
throughput analytical methodologies in the various “-omic” sciences,
as well as advances in nanotechnology, imaging, and bioinformatics.
Development in these areas will continue with support from both
the public and private sectors. Improved understanding of disease at
the molecular level and of pathophysiologic processes, along with
research innovations such as RNA interference and subcellular imag-
ing, will allow more precise analysis of mammalian pathophysiology.
Geographic information systems and sensor-based technologies will
enable greater precision in environmental and personal exposure
monitoring, integrating previously unavailable data into research. 
The NIEHS research portfolio will emphasize understanding of
molecular mechanisms of pathogenesis and directly link environ-
mental exposures with common diseases. We have established a new
Office of Translational Biomedicine at the NIEHS to facilitate
interdisciplinary and cross-disciplinary research endeavors, and we
will seek to collaborate more broadly across the medical research
community to maximize the potential gains from this approach. 
This new paradigm for research in the environmental health sci-
ences is our challenge and our vision for a healthier future. 
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We believe the disease-first approach will allow
environmental health science to greatly reduce the 
burden of human disease.
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